HCA Healthcare debt and dilution27

Borrowings, liquidity, share count and stock-based dilution.

Total debt

USD millions

$49,718M

Cash & equivalents

USD millions

$1,013M

Net debt

USD millions

$48,705M

Debt / equity

—

Debt / assets

78.61%

Net debt / EBITDA

× · TTM

—

Operating income is unavailable in the extracted statements for this period.

Debt / FCF

× · TTM

8.29×

Interest coverage

× · TTM

—

Operating income is unavailable in the extracted statements for this period.

Current ratio

0.99×

Diluted shares

Million shares

222.83M shares

Basic shares

Million shares

220.54M shares

Share count growth

-7.79%

Share repurchases

USD millions

$2,064M

Quarterly data

HCA Healthcare capital history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal period	Ended	Total debtUSD millions	Cash & equivalentsUSD millions	Net debtUSD millions	Debt / equity×	Debt / assets%	Net debt / EBITDA×	Debt / FCF×	Interest coverage×	Current ratio×	Diluted sharesMillion shares	Basic sharesMillion shares	Share count growth%	Share repurchasesUSD millions
FY 2026 Q2	Jun 30, 2026	49,718	1,013	48,705	—	78.61%	—	8.29×	—	0.99×	222.83	220.54	-7.79%	2,064
FY 2026 Q1	Mar 31, 2026	48,023	940	47,083	—	78.15%	—	6.06×	—	0.83×	226.65	223.59	-9.46%	1,571
FY 2025 Q4	Dec 31, 2025	46,492	1,040	45,452	—	76.57%	—	6.04×	—	0.97×	230.7	226.91	-10.01%	2,558
FY 2025 Q3	Sep 30, 2025	44,511	997	43,514	—	74.5%	—	5.5×	—	0.85×	236.18	232.89	-9.3%	2,498
FY 2025 Q2	Jun 30, 2025	44,483	939	43,544	—	74.72%	—	6.1×	—	0.98×	241.91	239.17	-8.42%	2,505
FY 2025 Q1	Mar 31, 2025	44,576	1,060	43,516	—	74.54%	—	9.01×	—	1.19×	249.44	246.94	-6.62%	2,506
FY 2024 Q4	Dec 31, 2024	43,031	1,933	41,098	77.53×	72.31%	—	7.63×	—	1.08×	255.31	252.15	-5.62%	1,700
FY 2024 Q3	Sep 30, 2024	42,965	2,888	40,077	54.66×	72.26%	—	7.31×	—	1.12×	259.92	256.76	-5.31%	1,795
FY 2024 Q2	Jun 30, 2024	40,880	831	40,049	30.53×	71.25%	—	8.36×	—	1.06×	264.07	261.16	-4.86%	1,367
FY 2024 Q1	Mar 31, 2024	40,191	1,284	38,907	31.65×	70.56%	—	7.4×	—	1.16×	268.02	264.44	-4.51%	1,180
FY 2023 Q4	Dec 31, 2023	39,593	935	38,658	37.35×	70.44%	—	8.45×	—	1.18×	271.19	267.16	-4.84%	910
FY 2023 Q3	Sep 30, 2023	39,346	891	38,455	110.21×	72.08%	—	8.99×	—	1.15×	275.42	271.17	-5.17%	1,140
FY 2023 Q2	Jun 30, 2023	38,932	862	38,070	84.45×	72.64%	—	7.89×	—	1.2×	278.2	274.49	-6.16%	915
FY 2023 Q1	Mar 31, 2023	38,856	842	38,014	167.48×	73.72%	—	9.14×	—	1.23×	280.96	276.91	-8.44%	846
FY 2022 Q4	Dec 31, 2022	38,084	908	37,176	—	72.63%	—	9.23×	—	1.38×	285.66	280.75	-9.22%	1,519
FY 2022 Q3	Sep 30, 2022	37,710	999	36,711	—	73.25%	—	9.03×	—	1.38×	289.85	285.96	-10.1%	698
FY 2022 Q2	Jun 30, 2022	38,903	858	38,045	—	75.42%	—	10.59×	—	1.55×	296.06	292.53	-10.86%	2,682
FY 2022 Q1	Mar 31, 2022	37,696	2,371	35,325	91.05×	72.2%	—	8.32×	—	1.43×	307.37	302.45	-10.55%	2,101
FY 2021 Q4	Dec 31, 2021	34,579	1,451	33,128	23.22×	68.15%	—	6.42×	—	1.41×	315.41	309.27	-8.75%	2,072
FY 2021 Q3	Sep 30, 2021	32,299	1,027	31,272	17.7×	65.17%	—	—	—	1.38×	324.03	318.07	-5.94%	2,329
FY 2021 Q2	Jun 30, 2021	32,572	1,120	31,452	18.2×	67.63%	—	50.89×	—	1.45×	332.61	328.17	-2.84%	2,287
FY 2021 Q1	Mar 31, 2021	31,072	1,030	30,042	12.52×	65.72%	—	4.31×	—	1.39×	343.32	338.12	-0.04%	1,527
FY 2020 Q4	Dec 31, 2020	31,004	1,793	29,211	10.72×	65.29%	—	4.85×	—	1.42×	345.37	338.92	-0.04%	0
FY 2020 Q3	Sep 30, 2020	30,964	6,588	24,376	23.84×	60.69%	—	2.59×	—	1.13×	343.35	338.17	-0.77%	0
FY 2020 Q2	Jun 30, 2020	30,942	4,638	26,304	54.48×	63.52%	—	2.89×	—	1.09×	341.6	337.76	-1.29%	0
FY 2020 Q1	Mar 31, 2020	34,861	731	34,130	—	76.75%	—	9.24×	—	1.57×	344.1	338.24	-1.35%	441
FY 2019 Q4	Dec 31, 2019	33,722	621	33,101	—	74.84%	—	9.79×	—	1.44×	346.78	339.07	-1.43%	272
FY 2019 Q3	Sep 30, 2019	34,245	559	33,686	—	77.99%	—	10.59×	—	1.51×	347.49	340.79	-1.46%	239
FY 2019 Q2	Jun 30, 2019	36,193	2,430	33,763	—	79.63%	—	11.59×	—	1.44×	348.37	342.17	-1.85%	242
FY 2019 Q1	Mar 31, 2019	34,815	531	34,284	—	80.26%	—	12.47×	—	1.05×	350.32	342.88	—	278
FY 2018 Q4	Dec 31, 2018	32,821	502	32,319	—	83.71%	—	10.3×	—	1.35×	352.87	343.99	—	335
FY 2018 Q3	Sep 30, 2018	33,107	578	32,529	—	87.02%	—	—	—	1.61×	353.64	345.82	—	302
FY 2018 Q2	Jun 30, 2018	33,192	868	32,324	—	87.94%	—	—	—	1.36×	355.04	348.62	—	470

Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Debt uses reported borrowings, with overlapping concepts treated as alternatives. Cash excludes restricted cash and short-term investments. Dilution compares split-normalized weighted average basic shares year over year. Share buyback spending does not by itself measure shares retired.

Market prices: Yahoo Finance · HCA, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Total debt: Reported borrowing balances. Uses an aggregate including current maturities, or current plus noncurrent debt. Adds separately disclosed short-term borrowings, with commercial paper as a fallback, unless the selected current/aggregate concept already includes them. Finance leases are included when part of the reported debt concept; undisclosed components are not estimated.
Cash & equivalents: Unrestricted reported cash and cash equivalents. Excludes short-term investments and restricted cash.
Net debt: Total debt − cash and equivalents. Negative means net cash.
Debt / equity: Total debt / equity including noncontrolling interests. Nonpositive equity yields unavailable.
Debt / assets: Total debt / total assets × 100.
Net debt / EBITDA: Period-end net debt / (TTM operating income + TTM depreciation and amortization). Negative net debt is retained.
Debt / FCF: Period-end reported debt / positive TTM free cash flow. Reflects the selected reported capex scope and SBC option.
Interest coverage: TTM operating income / positive TTM interest expense. IFRS finance costs can include more than interest.
Current ratio: Current assets / positive current liabilities.
Diluted shares: Reported weighted average diluted shares, normalized for subsequent recorded stock splits. Fourth-quarter counts use a day-weighted annual/nine-month reconstruction where possible.
Basic shares: Reported weighted average basic shares, normalized for subsequent recorded stock splits.
Share count growth: Year-over-year change in split-normalized weighted average basic shares × 100. A dilution proxy; negative means a lower share count.
Share repurchases: Reported cash payments for repurchase of common shares. This is spending, not a buyback yield.